Colipano, Justine .
HRN: 15-13-21 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/24/2024
CEFUROXIME 750MG (VIAL)
03/24/2024
03/30/2024
IVT
650mg
Q8
T/C UTI; WBC At 39.3
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Urinary TractIntra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes